slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
216,811-216,840 of 319,975
15
Data presented at EASL 2022. Shows longitudinal patient data for patients 42, 43, and 48.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Product1 hit
16
The slide uses a bulleted list to present key safety outcomes, including lack of serious adverse events and stability of laboratory markers.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
17
Arbutus Biopharma | Investor Presentation Deck | 25 slidesArbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
18
The slide uses a timeline-based process diagram to illustrate the clinical trial randomization and treatment arms.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
19
Shows two parallel trial arms with timelines and patient counts.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
20
The slide details the financial terms of the deal and the scope of the partnership.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
21
Arbutus Biopharma | Investor Presentation Deck | 25 slidesArbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
22
Includes two distinct charts: a bar chart showing IFN-y fold increase and a line chart showing tumor volume reduction over time.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
23
The slide uses a three-column layout to explain the scientific basis and product advantages.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
24
The slide includes a financial summary at the top and a list of clinical trial milestones with completion checkmarks.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · The Ask1 hit
25
Arbutus Biopharma | Investor Presentation Deck | 25 slidesArbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · The Ask1 hit
01
argenx SE | Results Presentation Deck | 14 slidesargenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
02
argenx SE | Results Presentation Deck | 14 slidesargenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
03
The slide uses a circular process flow diagram to illustrate the company's growth strategy.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations Beat · Key Takeaways1 hit
04
argenx SE | Results Presentation Deck | 14 slidesargenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations Beat · Key Takeaways1 hit
05
The slide uses a timeline-based clinical trial design framework.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
06
The slide outlines a randomized clinical trial structure.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
07
The slide uses a list format to communicate a roadmap of clinical milestones.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations Beat · RoadmapLoop · Maturity Curve1 hit
08
argenx SE | Results Presentation Deck | 14 slidesargenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations Beat · RoadmapLoop · Maturity Curve1 hit
09
The slide uses a 2D matrix-like structure to show expansion vectors.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations Beat · RoadmapLoop · Maturity Curve1 hit
10
The slide uses a central circular image overlaying a four-quadrant layout of strategic pillars.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations Beat · Key TakeawaysLoop · Quick Win Big Bet1 hit
11
The slide uses a chronological progression (Today vs Future) to outline product development milestones.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
12
The map uses teal dots for VYVGART and a purple dot for VYVGART Hytrulo, though the legend is implicit in the side tables.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
13
The slide combines corporate messaging with a personal patient story to humanize the clinical data.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
14
The slide uses a hub-and-spoke visual metaphor to represent corporate values.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
01
Aston Martin Lagonda | Results Presentation Deck | 18 slidesAston Martin Lagonda | Results Presentation Deck | 18 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Attention1 hit
02
Includes financial metrics (revenue, profit, EBITDA, liquidity, debt) and operational updates (product launches, financing, partnerships).Aston Martin Lagonda | Results Presentation Deck | 18 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Attention1 hit
03
Includes a decorative abstract image on the right side.Aston Martin Lagonda | Results Presentation Deck | 18 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Need1 hit
04
The slide uses a donut chart for volume distribution and a stacked bar chart for ASP comparison.Aston Martin Lagonda | Results Presentation Deck | 18 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Need1 hit
05
The slide uses a map-based visualization to show regional performance, with callout bubbles for percentage change and bar charts for absolute volume.Aston Martin Lagonda | Results Presentation Deck | 18 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Need1 hit